254 related articles for article (PubMed ID: 7874800)
1. Background correction in estimating initial renal uptake. Comparison between Tc-99m MAG3 and Tc-99m DTPA.
Inoue Y; Machida K; Honda N; Takahashi T; Mamiya T
Clin Nucl Med; 1994 Dec; 19(12):1049-54. PubMed ID: 7874800
[TBL] [Abstract][Full Text] [Related]
2. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.
Brolin G; Edenbrandt L; Granerus G; Olsson A; Afzelius D; Gustafsson A; Jonsson C; Hagerman J; Johansson L; Riklund K; Ljungberg M
Clin Physiol Funct Imaging; 2016 Mar; 36(2):146-54. PubMed ID: 25348641
[TBL] [Abstract][Full Text] [Related]
4. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.
Jung HS; Chung YA; Kim EN; Kim SH; Lee SY; Sohn HS; Park YH; Chung SK
Ann Nucl Med; 2005 Feb; 19(1):1-7. PubMed ID: 15770966
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
[TBL] [Abstract][Full Text] [Related]
6. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates.
Taylor A; Clark S; Ball T
Clin Nucl Med; 1994 Jul; 19(7):575-80. PubMed ID: 7924094
[TBL] [Abstract][Full Text] [Related]
8. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3.
Rossleigh MA; Thomas MY; Moase AL
Clin Nucl Med; 1994 Oct; 19(10):880-2. PubMed ID: 7805322
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
O'Malley JP; Ziessman HA; Chantarapitak N
Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
[TBL] [Abstract][Full Text] [Related]
11. Effect of administered activity on precision in the assessment of renal function using gamma camera renography.
Moonen M; Jacobsson L
Nucl Med Commun; 1997 Apr; 18(4):346-51. PubMed ID: 9170620
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for determination of glomerular filtration rate: low and high-dose Tc-99m-DTPA renography, predicted creatinine clearance method, and plasma sample method.
Assadi M; Eftekhari M; Hozhabrosadati M; Saghari M; Ebrahimi A; Nabipour I; Abbasi MZ; Moshtaghi D; Abbaszadeh M; Assadi S
Int Urol Nephrol; 2008; 40(4):1059-65. PubMed ID: 18690545
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest.
Inoue Y; Yoshikawa K; Yoshioka N; Watanabe T; Saegusa S; Kaneko Y; Yokoyama I; Ohtomo K
J Nucl Med; 2000 Dec; 41(12):1947-54. PubMed ID: 11138677
[TBL] [Abstract][Full Text] [Related]
14. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical.
Caglar M; Gedik GK; Karabulut E
Nucl Med Commun; 2008 Nov; 29(11):1002-5. PubMed ID: 18836380
[TBL] [Abstract][Full Text] [Related]
15. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
[TBL] [Abstract][Full Text] [Related]
16. Background subtraction in technetium-99m-MAG3 renography.
Taylor A; Thakore K; Folks R; Halkar R; Manatunga A
J Nucl Med; 1997 Jan; 38(1):74-9. PubMed ID: 8998155
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
Taylor A; Ziffer JA; Eshima D
Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry of
Arteaga MV; Caballero VM; Rengifo KM
Appl Radiat Isot; 2018 Aug; 138():25-28. PubMed ID: 28781122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
